North Peak Capital Management, LLC
Long book
$601.3M
Q1 2026
Positions
7
Top-10 weight
100%
concentration
Last quarter
+46.1%
SPY +14.8%
Turnover
40%
of book per quarter
Strategy in plain words
auto-generated from filingsNorth Peak Capital Management, LLC is a diversified fundamental manager, running a $601.3M US long book across 7 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: HILTON GRAND VACATIONS INC, CARVANA CO, SCHWAB (CHARLES) CORP, DRIVEN BRANDS HOLDINGS INC, HAEMONETICS CORP/MASS.
Over the last 9 quarters its long book ran on average 0.5pp per quarter ahead of the S&P 500, beating the index in 5 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-9.8%
Q2 2024
-2.4%
Q3 2024
+8.1%
Q4 2024
+1.1%
Q1 2025
+12.6%
Q2 2025
+0.9%
Q3 2025
+7.8%
Q4 2025
-19.4%
Q1 2026
+46.1%
Sector allocation
Services media 43%
Consumer discretionary 24%
Financials 21%
Healthcare 12%
Long book by quarter
What does North Peak own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| HGV HILTON GRAND VACATIONS INC | Services media | 4.4M | $173.3M | 28.8% | -14.4% |
| CVNA CARVANA CO | Consumer discretionary | 421.0K | $132.3M | 22.0% | +7.9% |
| SCHW SCHWAB (CHARLES) CORP | Financials | 1.2M | $112.9M | 18.8% | -2.7% |
| DRVN DRIVEN BRANDS HOLDINGS INC | Services media | 5.1M | $63.7M | 10.6% | +26.7% |
| HAE HAEMONETICS CORP/MASS | Healthcare | 999.0K | $56.3M | 9.4% | -9.4% |
| AGL AGILON HEALTH INC | Healthcare | 1.5M | $12.2M | 2.0% | New |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 14, 2026 | 7 | $601.3M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 10 | $1.18B | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 13, 2025 | 9 | $1.14B | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 13, 2025 | 8 | $1.27B | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 14, 2025 | 8 | $996.2M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 13, 2025 | 7 | $754.9M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 13, 2024 | 7 | $711.3M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 14, 2024 | 8 | $851.4M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 8 | $899.8M | canonical | SEC ↗ |
Similar funds
DIAMANT ASSET MANAGEMENT, INC. LILLY ENDOWMENT INCBROOKFIELD Corp /ON/GQG Partners LLCMITSUBISHI UFJ FINANCIAL GROUP INCNewport Trust Company, LLCVIKING GLOBAL INVESTORS LPPARNASSUS INVESTMENTS, LLC MASTERCARD FOUNDATION ASSET MANAGEMENT CORPPZENA INVESTMENT MANAGEMENT LLCCOATUE MANAGEMENT LLCWinslow Capital Management, LLC